1) Curative effect of radiation
放射疗效
2) radiotherapeutic effect
放疗疗效
1.
Study on the precedence between spontaneous apoptosis and radiation-induced apoptosis for predicting radiotherapeutic effect of cervical carcinoma;
宫颈鳞癌患者组织自发性凋亡和辐射诱导凋亡与放疗疗效的关系
3) radiotherapy
[英][,reɪdiəʊ'θerəpi] [美]['redɪo'θɛrəpɪ]
放射治疗
1.
Application of nano- and micro-magnetic composite particles in radiotherapy;
纳微米磁性复合粒子在放射治疗中的应用研究进展
2.
Radiotherapy and safety management of protection;
放射治疗与防护安全管理
3.
Analysis of whole brain radiotherapy plus stereotactic radiosurgery in treatment of brain metastases from lung cancer;
肺癌脑转移全脑放射治疗联合立体定向放射外科治疗分析
4) Radiotherapy
[英][,reɪdiəʊ'θerəpi] [美]['redɪo'θɛrəpɪ]
放射疗法
1.
Synthesis of Radiosensitizer in Radiotherapy;
放射疗法中致敏药物的合成
2.
Methods Retrospective analysis were performed in 75 germinoma patients with 104 lesions totally that were clinically verified by radiotherapy, including 51 patients with single lesion, 19 patients with two lesions and 5 patients with three lesions.
结果2种实验性放射疗法剂量对肿瘤病灶数目的影响未见显著性差异。
3.
Objective To recommend a radiotherapy treatment scheme for eosinophific lymphoid grannuloma (ELG), and evaluate the result.
结论放射疗法是治疗嗜酸性淋巴肉芽肿的有效方法,推荐治疗剂量为30~40Gy/3~4周。
5) Radiation Therapy
放射治疗
1.
The late clinical observation for metastatic cervical node treated with Radiation therapy and microwave therapy;
放射治疗加微波热疗治疗颈部淋巴结转移癌的近期疗效观察
2.
Therapeutic results of TAI regimen chemotherapy combined with radiation therapy in the treatment of advanced rectal carcinoma;
TAI联合放射治疗晚期直肠癌的临床研究
6) Radiotheraphy
放射治疗
1.
Designing of the radiotheraphy two-dimensional TPS;
放射治疗实时二维治疗计划系统的设计
2.
BACKGROUND & OBJECTIVE: Radiotheraphy is the standard adjuvant therapy to intracranial tumor after surgery.
背景与目的:颅内肿瘤的放射治疗大多是手术后的辅助治疗,高能质子束有尾部剂量快速降落现象,其物理特性和生物特性均优于光子,颅内肿瘤是质子放射治疗的最佳适应证之一,特别是对部分颅底肿瘤的疗效优于开颅手术,而无手术的风险和并发症。
3.
The article introduces a mathod of the radiotheraphy fieldsize haphazard point dose automatically calculating.
本文介绍了放射治疗射野任意点剂量自动计算的实现方法。
补充资料：放射性碘标记的放射性药物
分子式：
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
CAS号：
性质： 131I是最早用于临床的放射性核素之一。临床上常用的碘标放射性药物有：(1)Nal31I，用于甲状腺显像和甲亢治疗；(2)心肌显像用131I(123I)-CO-长链脂肪酸；(3)脑功能显像用123I(131I)-IMP(N-异丙基对碘安非他命，N-isopropyl-p-iodoamphetamine)，123I(131I)-HIPDM[N，N,N′-trimethyl-N′-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine]；(4)受体显像用123I(131I)标记变体配体，如D1，D2，乙酰胆碱，安定类受体显像剂；(5)用于放射免疫显像和治疗的131I标记抗肿病抗体；(6)肾上腺显像剂131I-6-碘胆固醇、131I-间-碘苄胍等。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条